Editorial: When the death penalty can be bad for business
by Los Angeles Times
Aug 17, 2018
2 minutes
Nebraska's execution of convicted double-murderer Carey Dean Moore Tuesday morning came despite opposition from an unusual source: a pharmaceutical company, Fresenius Kabi, that believed it manufactured two of the drugs Nebraska uses in its three-drug lethal injection protocol.
Federal courts rejected the company's legal challenge, which accused Nebraska
You’re reading a preview, subscribe to read more.
Start your free 30 days